Company profile ZYNE
After 39 days of this quarter the interest is at 13.0. Based on that we can calculate that during remaining 52 days it will total up to 30.0. Zynerba Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+114.3%) but lower than previous quarter (-47.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 66 | 189 186.4% QoQ | 121 -36.0% QoQ | 66 -45.5% QoQ |
| 2020 | 75 13.6% YoY 13.6% QoQ | 77 -59.3% YoY 2.7% QoQ | 65 -46.3% YoY -15.6% QoQ | 32 -51.5% YoY -50.8% QoQ |
| 2021 | 283 277.3% YoY 784.4% QoQ | 137 77.9% YoY -51.6% QoQ | 51 -21.5% YoY -62.8% QoQ | 53 65.6% YoY 3.9% QoQ |
| 2022 | 29 -89.8% YoY -45.3% QoQ | 12 -91.2% YoY -58.6% QoQ | 8 -84.3% YoY -33.3% QoQ | 13 -75.5% YoY 62.5% QoQ |
| 2023 | 14 -51.7% YoY 7.7% QoQ | 26 116.7% YoY 85.7% QoQ | 60 650.0% YoY 130.8% QoQ | 57 338.5% YoY -5.0% QoQ |
| 2024 | 13 -7.1% YoY -77.2% QoQ | - | - | - |
The average 5 years interest of Zynerba Pharmaceuticals was 5.54 per week. The last year interest of Zynerba Pharmaceuticals compared to the last 5 years has changed by -43.5%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -64.91%.
After 39 days of this quarter the interest is at 93.0. Based on that we can calculate that during remaining 52 days it will total up to 217.0. Zygel expected interest is significantly higher compared to previous quarter (+138.5%) and same quarter last year (+119.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 36 | 113 213.9% QoQ | 114 0.9% QoQ | 117 2.6% QoQ |
| 2020 | 37 2.8% YoY -68.4% QoQ | 273 141.6% YoY 637.8% QoQ | 129 13.2% YoY -52.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 58 56.8% YoY inf% QoQ | 0 -100.0% YoY -100.0% QoQ | 40 -69.0% YoY inf% QoQ | 25 inf% YoY -37.5% QoQ |
| 2022 | 119 105.2% YoY 376.0% QoQ | 93 inf% YoY -21.8% QoQ | 64 60.0% YoY -31.2% QoQ | 63 152.0% YoY -1.6% QoQ |
| 2023 | 99 -16.8% YoY 57.1% QoQ | 105 12.9% YoY 6.1% QoQ | 141 120.3% YoY 34.3% QoQ | 91 44.4% YoY -35.5% QoQ |
| 2024 | 93 -6.1% YoY 2.2% QoQ | - | - | - |
The average 5 years interest of Zygel was 6.93 per week. The last year interest of Zygel compared to the last 5 years has changed by 37.09%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 29.96%.
There is not enough data for transdermal cannabinoid therapies to provide analysis
There is not enough data for transdermal cannabinoid therapies to provide correlation calculation
There is not enough data for transdermal cannabinoid therapies to provide analysis
There is not enough data for rare neuropsychiatric disorders to provide analysis
There is not enough data for rare neuropsychiatric disorders to provide correlation calculation
There is not enough data for rare neuropsychiatric disorders to provide analysis
There is not enough data for near-rare neuropsychiatric disorders to provide analysis
There is not enough data for near-rare neuropsychiatric disorders to provide correlation calculation
There is not enough data for near-rare neuropsychiatric disorders to provide analysis
After 39 days of this quarter the interest is at 217.0. Based on that we can calculate that during remaining 52 days it will total up to 506.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 429 | 646 50.6% QoQ | 639 -1.1% QoQ | 600 -6.1% QoQ |
| 2020 | 856 99.5% YoY 42.7% QoQ | 837 29.6% YoY -2.2% QoQ | 772 20.8% YoY -7.8% QoQ | 590 -1.7% YoY -23.6% QoQ |
| 2021 | 747 -12.7% YoY 26.6% QoQ | 589 -29.6% YoY -21.2% QoQ | 553 -28.4% YoY -6.1% QoQ | 525 -11.0% YoY -5.1% QoQ |
| 2022 | 569 -23.8% YoY 8.4% QoQ | 518 -12.1% YoY -9.0% QoQ | 504 -8.9% YoY -2.7% QoQ | 459 -12.6% YoY -8.9% QoQ |
| 2023 | 537 -5.6% YoY 17.0% QoQ | 528 1.9% YoY -1.7% QoQ | 520 3.2% YoY -1.5% QoQ | 531 15.7% YoY 2.1% QoQ |
| 2024 | 217 -59.6% YoY -59.1% QoQ | - | - | - |
The average 5 years interest of pharmaceuticals was 46.61 per week. The last year interest of pharmaceuticals compared to the last 5 years has changed by -13.73%. The interest for pharmaceuticals is seasonal. The last year interest is quite lower compared to 5 years ago. It has decreased by -19.24%.
There is not enough data for clinical stage specialty pharmaceutical company to provide analysis
There is not enough data for clinical stage specialty pharmaceutical company to provide correlation calculation
There is not enough data for clinical stage specialty pharmaceutical company to provide analysis
There is not enough data for drug manufacturers specialty to provide analysis
There is not enough data for drug manufacturers specialty to provide correlation calculation
There is not enough data for drug manufacturers specialty to provide analysis
There is not enough data for permeation-enhanced gel to provide analysis
There is not enough data for permeation-enhanced gel to provide correlation calculation
There is not enough data for permeation-enhanced gel to provide analysis
After 39 days of this quarter the interest is at 133.0. Based on that we can calculate that during remaining 52 days it will total up to 310.0. transdermal delivery expected interest is significantly higher compared to same quarter last year (+65.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 223 | 301 35.0% QoQ | 175 -41.9% QoQ | 182 4.0% QoQ |
| 2020 | 294 31.8% YoY 61.5% QoQ | 274 -9.0% YoY -6.8% QoQ | 305 74.3% YoY 11.3% QoQ | 145 -20.3% YoY -52.5% QoQ |
| 2021 | 246 -16.3% YoY 69.7% QoQ | 410 49.6% YoY 66.7% QoQ | 135 -55.7% YoY -67.1% QoQ | 221 52.4% YoY 63.7% QoQ |
| 2022 | 239 -2.8% YoY 8.1% QoQ | 265 -35.4% YoY 10.9% QoQ | 225 66.7% YoY -15.1% QoQ | 169 -23.5% YoY -24.9% QoQ |
| 2023 | 187 -21.8% YoY 10.7% QoQ | 157 -40.8% YoY -16.0% QoQ | 187 -16.9% YoY 19.1% QoQ | 346 104.7% YoY 85.0% QoQ |
| 2024 | 133 -28.9% YoY -61.6% QoQ | - | - | - |
The average 5 years interest of transdermal delivery was 18.46 per week. The last year interest of transdermal delivery compared to the last 5 years has changed by -1.46%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 0.33%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. AllTranz expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 170 | 177 4.1% QoQ | 103 -41.8% QoQ | 0 -100.0% QoQ |
| 2020 | 16 -90.6% YoY inf% QoQ | 134 -24.3% YoY 737.5% QoQ | 100 -2.9% YoY -25.4% QoQ | 53 inf% YoY -47.0% QoQ |
| 2021 | 24 50.0% YoY -54.7% QoQ | 78 -41.8% YoY 225.0% QoQ | 141 41.0% YoY 80.8% QoQ | 181 241.5% YoY 28.4% QoQ |
| 2022 | 109 354.2% YoY -39.8% QoQ | 88 12.8% YoY -19.3% QoQ | 131 -7.1% YoY 48.9% QoQ | 137 -24.3% YoY 4.6% QoQ |
| 2023 | 67 -38.5% YoY -51.1% QoQ | 126 43.2% YoY 88.1% QoQ | 108 -17.6% YoY -14.3% QoQ | 97 -29.2% YoY -10.2% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of AllTranz was 7.82 per week. The last year interest of AllTranz compared to the last 5 years has changed by -2.17%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -11.56%.
There is not enough data for ISS Governance QualityScore to provide analysis
There is not enough data for ISS Governance QualityScore to provide correlation calculation
There is not enough data for ISS Governance QualityScore to provide analysis
There is not enough data for corporate governance risk. to provide analysis
There is not enough data for corporate governance risk. to provide correlation calculation
There is not enough data for corporate governance risk. to provide analysis